Revenue Breakdown
Composition ()
No data
Revenue Streams
Cardinal Health Inc (CAH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Cardinal Health At Home, accounting for 1.7% of total sales, equivalent to $1.11B. Other significant revenue streams include Nuclear Precision Health Services and Opti freight logistics. Understanding this composition is critical for investors evaluating how CAH navigates market cycles within the Pharmaceuticals industry.
Profitability & Margins
Evaluating the bottom line, Cardinal Health Inc maintains a gross margin of 3.49%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.20%, while the net margin is 0.71%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively CAH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, CAH competes directly with industry leaders such as COR and HSIC. With a market capitalization of $49.89B, it holds a significant position in the sector. When comparing efficiency, CAH's gross margin of 3.49% stands against COR's 3.23% and HSIC's 28.69%. Such benchmarking helps identify whether Cardinal Health Inc is trading at a premium or discount relative to its financial performance.
